Elevated expression levels of androgen receptors and matrix metalloproteinase-2 and -9 in 30 cases of hepatocellular carcinoma compared with adjacent tissues as predictors of cancer invasion and staging

Experimental and Therapeutic Medicine

Volumn 9, Issue 3, 2015, Pages 905-908

  Zhang, Yan ^a   Shen, Yucheng ^a   Cao, Bin ^a   Yan, Aiting ^a   Ji, Haoming ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Androgen receptor; Hepatocellular carcinoma; Matrix metalloproteinase 2; Matrix metalloproteinase 9

Indexed keywords

FOCAL ADHESION KINASE 2; GENOMIC DNA;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; MALE; MOLECULAR DIAGNOSIS; PAROXYSMAL KINESIGENIC DYSKINESIA; PATHOGENESIS; POLYMERASE CHAIN REACTION; QUANTITATIVE ASSAY; SEQUENCE ANALYSIS;

EID: 84922020960     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.2150     Document Type: Article

References (16)

1. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
2. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Yu MW and Chen CJ: Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res 53: 790-794, 1993.
4. Yu MW, Cheng SW, Lin MW, et al: Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 92: 2023-2028, 2000.
5. Lee CM, Lu SN, Changchien CS, et al: Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 86: 1143-1150, 1999.
6. Hashemi M and Ghavami S: Hepatocellular recurrence after orthotopic liver transplantation: Is combination of α-fetoprotein and glypican-3 a reliable marker?: Hepatocellular recurrence after orthotopic liver trasplantation. Hepat Mon 11: 155-156, 2011.
7. Bruix J and Llovet JM: Major achievements in hepatocellular carcinoma. Lancet 373: 614-616, 2009.
8. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
9. Ma WL, Hsu CL, Wu MH, Wu CT, Wu CC, Lai JJ, Jou YS, Chen CW, Yeh S and Chang C: Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology 135: 947-955, 2008.
10. Tavian D, De Petro G, Pitozzi A, et al: Androgen receptor mRNA under-expression in poorly differentiated human hepatocellular carcinoma. Histol Histopathol 17: 1113-1119, 2002.
11. Feng H, Cheng AS, Tsang DP, et al: Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis. J Clin Invest 121: 3159-3175, 2011.
12. Boonyaratanakornkit V and Edwards DP: Receptor mechanisms mediating non-genomic actions of sex steroids. Semin Reprod Med 25: 139-153, 2007.
13. Lelongt B, Trugnan G, Murphy G and Ronco PM: Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J Cell Biol 136: 1363-1373, 1997.
14. Li J, Lau GK, Chen L, Dong SS, et al: Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One 6: e21816, 2011.
15. Yang P, Yuan W, He J, Wang J, et al: Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma. Implications for tumor progression and prognosis. Hepatol Res 39: 1169-1177, 2009.
16. Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67, 2010.